Nonoperating Income (Expense) in USD of AGILE THERAPEUTICS INC from 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Agile Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and change rate from 2015 to Q2 2024.
  • Agile Therapeutics Inc Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was -$9.13M, a 793% decline year-over-year.
  • Agile Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending 30 Jun 2024 was -$2.3M, a 113% decline year-over-year.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was $5.42M, a 75.9% decline from 2022.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was $22.5M.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$62K, a 97.8% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.3M -$9.13M -$10.4M -793% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $8.14M $4.04M +$2.72M +207% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $5.42M -$417K -$3.37M -114% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $8.78M $3.2M -$9.58M -74.9% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $18.4M $1.32M -$4.91M -78.9% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $23.3M $1.32M +$805K +157% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $22.5M $2.95M +$120K +4.24% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $22.3M $12.8M +$13.8M 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $8.57M $6.23M +$7.22M 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $1.36M $513K +$1.42M 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$62K $2.83M +$3.71M 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 -$3.77M -$998K -$130K -15% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$3.64M -$986K -$199K -25.3% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$3.44M -$906K -$640K -241% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$2.8M -$879K -$963K -1146% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2023
Q3 2020 -$1.84M -$868K -$935K -1396% 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q2 2020 -$902K -$787K -$850K -1349% 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021
Q1 2020 -$52K -$266K -$304K -800% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $252K $84K +$167K 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2022
Q3 2019 $85K $67K +$244K 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$159K $63K +$260K 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$419K $38K +$302K 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q4 2018 -$721K -$83K +$169K +67.1% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021
Q3 2018 -$890K -$177K +$224K +55.9% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019
Q2 2018 -$1.11M -$197K +$253K +56.2% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 -$1.37M -$264K +$126K +32.3% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 -$1.49M -$252K 01 Oct 2017 31 Dec 2017 10-K 20 Feb 2020
Q3 2017 -$401K 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 -$450K 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018
Q1 2017 -$390K 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018

AGILE THERAPEUTICS INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.42M -$17.1M -75.9% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $22.5M +$22.5M 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$62K +$2.74M +97.8% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 -$2.8M -$3.05M -1211% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
2019 $252K +$973K 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 -$721K +$772K +51.7% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 -$1.49M +$602K +28.7% 01 Jan 2017 31 Dec 2017 10-K 20 Feb 2020
2016 -$2.1M +$1.12M +34.9% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 -$3.22M 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.